{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:51:04Z","timestamp":1773809464559,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00296-019-04461-y","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T17:26:23Z","timestamp":1571851583000},"page":"437-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-4207","authenticated-orcid":false,"given":"Victoria","family":"Furer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-1799","authenticated-orcid":false,"given":"Shani","family":"Shenhar-Tsarfaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Berliner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2881-7739","authenticated-orcid":false,"given":"Uri","family":"Arad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4561-3137","authenticated-orcid":false,"given":"Daphna","family":"Paran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Mailis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ori","family":"Rogowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zeltser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzhak","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagit","family":"Matz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9329-3639","authenticated-orcid":false,"given":"Ori","family":"Elkayam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"issue":"2","key":"4461_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","volume":"72","author":"A Jamnitski","year":"2013","unstructured":"Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 72(2):211\u2013216. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2011-201194","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4461_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","volume":"74","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, Troxel AB, Hennessy S, Kimmel SE, Margolis DJ, Choi H, Mehta NN, Gelfand JM (2015) Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 74(2):326\u2013332. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-205675","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4461_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/acr.22926","volume":"69","author":"A Polachek","year":"2017","unstructured":"Polachek A, Touma Z, Anderson M, Eder L (2017) Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 69(1):67\u201374. \nhttps:\/\/doi.org\/10.1002\/acr.22926","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"4461_CR4","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/annrheumdis-2016-210275","volume":"76","author":"O Schieir","year":"2017","unstructured":"Schieir O, Tosevski C, Glazier RH, Hogg-Johnson S, Badley EM (2017) Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Ann Rheum Dis 76(8):1396\u20131404. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-210275","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4461_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1136\/annrheumdis-2016-210390","volume":"76","author":"J Shen","year":"2017","unstructured":"Shen J, Wong KT, Cheng IT, Shang Q, Li EK, Wong P, Kun EW, Law MY, Yip R, Yim I, Ying S, Li M, Li TK, Wong CK, Zhu TY, Lee JJ, Chang M, Lee AP, Tam LS (2017) Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. Ann Rheum Dis 76(7):1237\u20131244. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-210390","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4461_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/acr.23094","volume":"69","author":"K Jafri","year":"2017","unstructured":"Jafri K, Bartels CM, Shin D, Gelfand JM, Ogdie A (2017) Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken) 69(1):51\u201357. \nhttps:\/\/doi.org\/10.1002\/acr.23094","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"4461_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/bor.0000000000000152","volume":"27","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Schwartzman S, Husni ME (2015) Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 27(2):118\u2013126. \nhttps:\/\/doi.org\/10.1097\/bor.0000000000000152","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"4461_CR8","doi-asserted-by":"publisher","first-page":"e000588","DOI":"10.1136\/rmdopen-2017-000588","volume":"3","author":"K Shah","year":"2017","unstructured":"Shah K, Paris M, Mellars L, Changolkar A, Mease PJ (2017) Real-world burden of comorbidities in US patients with psoriatic arthritis. RMD Open 3(2):e000588. \nhttps:\/\/doi.org\/10.1136\/rmdopen-2017-000588","journal-title":"RMD Open"},{"key":"4461_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2018.09.017","author":"F Abdolmaleki","year":"2018","unstructured":"Abdolmaleki F, Gheibi Hayat SM, Bianconi V, Johnston TP, Sahebkar A (2018) Atherosclerosis and immunity: a perspective. Trends Cardiovasc Med. \nhttps:\/\/doi.org\/10.1016\/j.tcm.2018.09.017","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"4461_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Sodergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76(1):17\u201328. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-209775","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4461_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","volume":"110","author":"CS Crowson","year":"2012","unstructured":"Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE (2012) Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 110(3):420\u2013424. \nhttps:\/\/doi.org\/10.1016\/j.amjcard.2012.03.044","journal-title":"Am J Cardiol"},{"issue":"7","key":"4461_CR12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/acr.22536","volume":"67","author":"FC Ernste","year":"2015","unstructured":"Ernste FC, Sanchez-Menendez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H (2015) Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study. Arthritis Care Res (Hoboken) 67(7):1015\u20131021. \nhttps:\/\/doi.org\/10.1002\/acr.22536","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"4461_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino Sr","year":"2008","unstructured":"D\u2019Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6):743\u2013753. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.699579","journal-title":"Circulation"},{"issue":"14","key":"4461_CR14","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","volume":"113","author":"KC Park","year":"2017","unstructured":"Park KC, Gaze DC, Collinson PO, Marber MS (2017) Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res 113(14):1708\u20131718. \nhttps:\/\/doi.org\/10.1093\/cvr\/cvx183","journal-title":"Cardiovasc Res"},{"issue":"13","key":"4461_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","volume":"123","author":"JT Saunders","year":"2011","unstructured":"Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM (2011) Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123(13):1367\u20131376. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.005264","journal-title":"Circulation"},{"issue":"22","key":"4461_CR16","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1001\/jama.2010.1768","volume":"304","author":"JA de Lemos","year":"2010","unstructured":"de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK (2010) Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304(22):2503\u20132512. \nhttps:\/\/doi.org\/10.1001\/jama.2010.1768","journal-title":"JAMA"},{"issue":"5","key":"4461_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jacc.2017.05.062","volume":"70","author":"P Willeit","year":"2017","unstructured":"Willeit P, Welsh P, Evans JDW, Tschiderer L, Boachie C, Jukema JW, Ford I, Trompet S, Stott DJ, Kearney PM, Mooijaart SP, Kiechl S, Di Angelantonio E, Sattar N (2017) High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. J Am Coll Cardiol 70(5):558\u2013568. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2017.05.062","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4461_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13075-017-1352-7","volume":"19","author":"G Divard","year":"2017","unstructured":"Divard G, Abbas R, Chenevier-Gobeaux C, Chanson N, Escoubet B, Chauveheid MP, Dossier A, Papo T, Dehoux M, Sacre K (2017) High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study. Arthritis Res Ther 19(1):132. \nhttps:\/\/doi.org\/10.1186\/s13075-017-1352-7","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"4461_CR19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/acr.22547","volume":"67","author":"J Avouac","year":"2015","unstructured":"Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y (2015) Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide. Arthritis Care Res (Hoboken) 67(7):1022\u20131030. \nhttps:\/\/doi.org\/10.1002\/acr.22547","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"4461_CR20","doi-asserted-by":"publisher","first-page":"e38930","DOI":"10.1371\/journal.pone.0038930","volume":"7","author":"WS Bradham","year":"2012","unstructured":"Bradham WS, Bian A, Oeser A, Gebretsadik T, Shintani A, Solus J, Estis J, Lu QA, Todd J, Raggi P, Stein CM (2012) High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation. PLoS One 7(6):e38930. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0038930","journal-title":"PLoS One"},{"issue":"6","key":"4461_CR21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/rheumatology\/key057","volume":"57","author":"GA Karpouzas","year":"2018","unstructured":"Karpouzas GA, Estis J, Rezaeian P, Todd J, Budoff MJ (2018) High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis. Rheumatology (Oxford) 57(6):1080\u20131088. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/key057","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"4461_CR22","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673. \nhttps:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4461_CR23","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/ard.2009.122259","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS (2010) Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69(8):1441\u20131447. \nhttps:\/\/doi.org\/10.1136\/ard.2009.122259","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4461_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/annrheumdis-2016-209511","volume":"76","author":"D Aletaha","year":"2017","unstructured":"Aletaha D, Alasti F, Smolen JS (2017) Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression. Ann Rheum Dis 76(2):418\u2013421. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-209511","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4461_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"11","key":"4461_CR26","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","volume":"75","author":"RG Lambert","year":"2016","unstructured":"Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG, Sieper J, Baraliakos X, Bennett A, Braun J, Burgos-Vargas R, Dougados M, Pedersen SJ, Jurik AG, Maksymowych WP, Marzo-Ortega H, Ostergaard M, Poddubnyy D, Reijnierse M, van den Bosch F, van der Horst-Bruinsma I, Landewe R (2016) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis 75(11):1958\u20131963. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2015-208642","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4461_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U (1978) Severe psoriasis\u2013oral therapy with a new retinoid. Dermatologica 157(4):238\u2013244","journal-title":"Dermatologica"},{"issue":"6","key":"4461_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1373\/clinchem.2010.159350","volume":"57","author":"SK Agarwal","year":"2011","unstructured":"Agarwal SK, Avery CL, Ballantyne CM, Catellier D, Nambi V, Saunders J, Sharrett AR, Coresh J, Heiss G, Hoogeveen RC (2011) Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin Chem 57(6):891\u2013897. \nhttps:\/\/doi.org\/10.1373\/clinchem.2010.159350","journal-title":"Clin Chem"},{"issue":"5","key":"4461_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1001\/jamacardio.2016.0765","volume":"1","author":"JW McEvoy","year":"2016","unstructured":"McEvoy JW, Chen Y, Ndumele CE, Solomon SD, Nambi V, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E (2016) Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol 1(5):519\u2013528. \nhttps:\/\/doi.org\/10.1001\/jamacardio.2016.0765","journal-title":"JAMA Cardiol"},{"issue":"2","key":"4461_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1373\/clinchem.2009.132654","volume":"56","author":"E Giannitsis","year":"2010","unstructured":"Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA (2010) Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 56(2):254\u2013261. \nhttps:\/\/doi.org\/10.1373\/clinchem.2009.132654","journal-title":"Clin Chem"},{"issue":"11","key":"4461_CR31","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1373\/clinchem.2012.192716","volume":"58","author":"FS Apple","year":"2012","unstructured":"Apple FS, Ler R, Murakami MM (2012) Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58(11):1574\u20131581. \nhttps:\/\/doi.org\/10.1373\/clinchem.2012.192716","journal-title":"Clin Chem"},{"issue":"14","key":"4461_CR32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","volume":"367","author":"C Emerging Risk Factors","year":"2012","unstructured":"Emerging Risk Factors C, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Bjorkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D\u2019Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engstrom G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jorgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 367(14):1310\u20131320. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1107477","journal-title":"N Engl J Med"},{"issue":"3","key":"4461_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74(3):480\u2013489. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2014-206624","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4461_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/art.40366","volume":"70","author":"L Eder","year":"2018","unstructured":"Eder L, Joshi AA, Dey AK, Cook R, Siegel EL, Gladman DD, Mehta NN (2018) Association of tumor necrosis factor inhibitor treatment with reduced indices of subclinical atherosclerosis in patients with psoriatic disease. Arthritis Rheumatol 70(3):408\u2013416. \nhttps:\/\/doi.org\/10.1002\/art.40366","journal-title":"Arthritis Rheumatol"},{"key":"4461_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2016.10.016","volume":"254","author":"P Welsh","year":"2016","unstructured":"Welsh P, Tuckwell K, McInnes IB, Sattar N (2016) Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis. Atherosclerosis 254:167\u2013171. \nhttps:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.10.016","journal-title":"Atherosclerosis"},{"issue":"12","key":"4461_CR36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/nejmoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, Group CT (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119\u20131131. \nhttps:\/\/doi.org\/10.1056\/nejmoa1707914","journal-title":"N Engl J Med"},{"issue":"22","key":"4461_CR37","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1001\/jama.2010.1708","volume":"304","author":"CR deFilippi","year":"2010","unstructured":"deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL (2010) Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 304(22):2494\u20132502. \nhttps:\/\/doi.org\/10.1001\/jama.2010.1708","journal-title":"JAMA"},{"issue":"2","key":"4461_CR38","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","volume":"76","author":"JK Eriksson","year":"2017","unstructured":"Eriksson JK, Jacobsson L, Bengtsson K, Askling J (2017) Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis 76(2):364\u2013370. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-209315","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4461_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","volume":"19","author":"K Bengtsson","year":"2017","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindstrom U, Askling J, Jacobsson LTH (2017) Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther 19(1):102. \nhttps:\/\/doi.org\/10.1186\/s13075-017-1315-z","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04461-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T23:17:14Z","timestamp":1603322234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04461-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4461"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04461-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been approved by the ethics committee and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"All persons gave their informed consent prior to their inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}